111 related articles for article (PubMed ID: 30888409)
1. Poly-Arginine Peptides R18 and R18D Improve Functional Outcomes After Endothelin-1-Induced Stroke in the Sprague Dawley Rat.
Meloni BP; South SM; Gill DA; Marriott AL; Déziel RA; Jacques A; Blacker DJ; Knuckey NW
J Neuropathol Exp Neurol; 2019 May; 78(5):426-435. PubMed ID: 30888409
[TBL] [Abstract][Full Text] [Related]
2. Comparison of neuroprotective efficacy of poly-arginine R18 and R18D (D-enantiomer) peptides following permanent middle cerebral artery occlusion in the Wistar rat and in vitro toxicity studies.
Milani D; Bakeberg MC; Cross JL; Clark VW; Anderton RS; Blacker DJ; Knuckey NW; Meloni BP
PLoS One; 2018; 13(3):e0193884. PubMed ID: 29513757
[TBL] [Abstract][Full Text] [Related]
3. Poly-arginine-18 peptides do not exacerbate bleeding, or improve functional outcomes following collagenase-induced intracerebral hemorrhage in the rat.
Liddle L; Reinders R; South S; Blacker D; Knuckey N; Colbourne F; Meloni B
PLoS One; 2019; 14(11):e0224870. PubMed ID: 31697775
[TBL] [Abstract][Full Text] [Related]
4. Comparative Assessment of the Proteolytic Stability and Impact of Poly-Arginine Peptides R18 and R18D on Infarct Growth and Penumbral Tissue Preservation Following Middle Cerebral Artery Occlusion in the Sprague Dawley Rat.
Milani D; Clark VW; Feindel KW; Blacker DJ; Bynevelt M; Edwards AB; Anderton RS; Knuckey NW; Meloni BP
Neurochem Res; 2021 May; 46(5):1166-1176. PubMed ID: 33523394
[TBL] [Abstract][Full Text] [Related]
5. Poly-arginine R18 and R18D (D-enantiomer) peptides reduce infarct volume and improves behavioural outcomes following perinatal hypoxic-ischaemic encephalopathy in the P7 rat.
Edwards AB; Cross JL; Anderton RS; Knuckey NW; Meloni BP
Mol Brain; 2018 Feb; 11(1):8. PubMed ID: 29426351
[TBL] [Abstract][Full Text] [Related]
6. Delayed 2-h post-stroke administration of R18 and NA-1 (TAT-NR2B9c) peptides after permanent and/or transient middle cerebral artery occlusion in the rat.
Milani D; Cross JL; Anderton RS; Blacker DJ; Knuckey NW; Meloni BP
Brain Res Bull; 2017 Oct; 135():62-68. PubMed ID: 28964774
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective efficacy of poly-arginine R18 and NA-1 (TAT-NR2B9c) peptides following transient middle cerebral artery occlusion in the rat.
Milani D; Cross JL; Anderton RS; Blacker DJ; Knuckey NW; Meloni BP
Neurosci Res; 2017 Jan; 114():9-15. PubMed ID: 27639457
[TBL] [Abstract][Full Text] [Related]
8. Poly-Arginine Peptide-18 (R18) Reduces Brain Injury and Improves Functional Outcomes in a Nonhuman Primate Stroke Model.
Meloni BP; Chen Y; Harrison KA; Nashed JY; Blacker DJ; South SM; Anderton RS; Mastaglia FL; Winterborn A; Knuckey NW; Cook DJ
Neurotherapeutics; 2020 Apr; 17(2):627-634. PubMed ID: 31833045
[TBL] [Abstract][Full Text] [Related]
9. Impact of poly-arginine peptides R18D and R18 on alteplase and tenecteplase thrombolysis in vitro, and neuroprotective stability to proteolysis.
Meloni BP; Blacker DJ; Edwards AB; Knuckey NW
J Thromb Thrombolysis; 2022 Jul; 54(1):172-182. PubMed ID: 35305237
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the safety of the cationic arginine-rich peptides (CARPs) poly-arginine-18 (R18 and R18D) in
Edwards AB; Mastaglia FL; Knuckey NW; Yip KH; Meloni B
Biochem Biophys Rep; 2022 Sep; 31():101305. PubMed ID: 35812346
[TBL] [Abstract][Full Text] [Related]
11. Poly-arginine peptides reduce infarct volume in a permanent middle cerebral artery rat stroke model.
Milani D; Clark VW; Cross JL; Anderton RS; Knuckey NW; Meloni BP
BMC Neurosci; 2016 May; 17(1):19. PubMed ID: 27142074
[TBL] [Abstract][Full Text] [Related]
12. The R18 Polyarginine Peptide Is More Effective Than the TAT-NR2B9c (NA-1) Peptide When Administered 60 Minutes after Permanent Middle Cerebral Artery Occlusion in the Rat.
Milani D; Knuckey NW; Anderton RS; Cross JL; Meloni BP
Stroke Res Treat; 2016; 2016():2372710. PubMed ID: 27247825
[TBL] [Abstract][Full Text] [Related]
13. Assessment of therapeutic window for poly-arginine-18D (R18D) in a P7 rat model of perinatal hypoxic-ischaemic encephalopathy.
Edwards AB; Anderton RS; Knuckey NW; Meloni BP
J Neurosci Res; 2018 Nov; 96(11):1816-1826. PubMed ID: 30146697
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the Neuroprotective Effects of Arginine-Rich Protamine Peptides, Poly-Arginine Peptides (R12-Cyclic, R22) and Arginine-Tryptophan-Containing Peptides Following In Vitro Excitotoxicity and/or Permanent Middle Cerebral Artery Occlusion in Rats.
Meloni BP; Milani D; Cross JL; Clark VW; Edwards AB; Anderton RS; Blacker DJ; Knuckey NW
Neuromolecular Med; 2017 Sep; 19(2-3):271-285. PubMed ID: 28523591
[TBL] [Abstract][Full Text] [Related]
15. Effect of Polyarginine Peptide R18D Following a Traumatic Brain Injury in Sprague-Dawley Rats.
Chiu LS; Anderton RS; Clark VW; Cross JL; Knuckey NW; Meloni BP
Curr Ther Res Clin Exp; 2020; 92():100584. PubMed ID: 32322314
[TBL] [Abstract][Full Text] [Related]
16. Assessment of recombinant tissue plasminogen activator (rtPA) toxicity in cultured neural cells and subsequent treatment with poly-arginine peptide R18D.
Kenna JE; Anderton RS; Knuckey NW; Meloni BP
Neurochem Res; 2020 May; 45(5):1215-1229. PubMed ID: 32140956
[TBL] [Abstract][Full Text] [Related]
17. In vitro cellular uptake and neuroprotective efficacy of poly-arginine-18 (R18) and poly-ornithine-18 (O18) peptides: critical role of arginine guanidinium head groups for neuroprotection.
MacDougall G; Anderton RS; Ouliel E; Gao J; Redmond SL; Knuckey NW; Meloni BP
Mol Cell Biochem; 2020 Jan; 464(1-2):27-38. PubMed ID: 31679100
[TBL] [Abstract][Full Text] [Related]
18. Delayed Administration of Tat-HA-NR2B9c Promotes Recovery After Stroke in Rats.
Zhou HH; Tang Y; Zhang XY; Luo CX; Gao LY; Wu HY; Chang L; Zhu DY
Stroke; 2015 May; 46(5):1352-8. PubMed ID: 25851770
[TBL] [Abstract][Full Text] [Related]
19. Assessment of R18, COG1410, and APP96-110 in Excitotoxicity and Traumatic Brain Injury.
Chiu LS; Anderton RS; Cross JL; Clark VW; Edwards AB; Knuckey NW; Meloni BP
Transl Neurosci; 2017; 8():147-157. PubMed ID: 29177102
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of cortical neuronal cultures treated with poly-arginine peptide-18 (R18) and exposed to glutamic acid excitotoxicity.
MacDougall G; Anderton RS; Mastaglia FL; Knuckey NW; Meloni BP
Mol Brain; 2019 Jul; 12(1):66. PubMed ID: 31315638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
